First, they wondered how healthcare outcomes might differ when patients took the drugs outside clinical trials, which have strict oversight to ensure participants take every dose
Trial data have shown decreases in serious cardiovascular complications, including cardiovascular mortality, nonlethal heart attacks, and nonfatal cerebrovascular accidents, among individuals with type 2 diabetes and pre-existing cardiovascular pathology or high cardiovascular risk [3,5,13,14,37]
Most recently, in a new structure of GLP-1R, a small molecule agonist, TT-OAD2, was shown to activate the receptor through binding of the helix IIECL1helix III region, revealing another ECD conformation 25
If youre using GLP-1 for weight loss or managing type 2 diabetes, you may be wondering: Does it also help with cholesterol? The short answer: yes there is good evidence that GLP-1 can modestly improve cholesterol and overall lipid profiles in some patients
DAYANAND C
It's also worth mentioning that LLY also currently pays a dividend yield of 0.71%, which makes it all the more attractive as a long-term holding, at least for income-focused investors
